Intriguingly, we observed that anti‐PD‐L1 therapy slightly increased the expression of SRC‐1 in tumor tissues, which may also be one of the reasons for the elevated PD‐L1 levels (Figure 6J). This evidence concerns the gene SRC and neoplasm.